Basic Information
About AroCell ABAroCell AB (AROC) is a Swedish company that develops standardized modern blood tests to support the prognosis and follow-up of cancer patients. AroCell's new technology is based on a patented method for measuring TK1 protein levels, providing valuable information about cell turnover rates. Tumors have high cell turnover rates (the speed of cell division and cell death). AroCell (AROC) is listed on Nasdaq First North with approximately 2,500 shareholders.